Do you support this bill?

Senate Bill S9279A

2025-2026 Legislative Session

Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment

download bill text pdf

Sponsored By

Current Bill Status - In Senate Committee Health Committee

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

Bill Amendments

2025-S9279 - Details

See Assembly Version of this Bill:
A3283
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add Art 32-B §3230, Pub Health L
Versions Introduced in 2023-2024 Legislative Session:
A10095

2025-S9279 - Summary

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

2025-S9279 - Sponsor Memo

2025-S9279 - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   9279
 
                             I N  S E N A T E
 
                             February 24, 2026
                                ___________
 
 Introduced  by Sen. GIANARIS -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in relation to the  operation  of
   gene synthesis providers and manufacturers of gene synthesis equipment
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Short title. This act shall be known and may  be  cited  as
 the "bioterrorism prevention act".
   §  2. The public health law is amended by adding a new article 32-B to
 read as follows:
                               ARTICLE 32-B
                            GENE SYNTHESIS LABS
 SECTION 3230. OPERATION OF GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF
                 GENE SYNTHESIS EQUIPMENT.
   § 3230. OPERATION OF GENE SYNTHESIS  PROVIDERS  AND  MANUFACTURERS  OF
 GENE  SYNTHESIS EQUIPMENT.   ANY GENE SYNTHESIS PROVIDER OR MANUFACTURER
 OF LABORATORY EQUIPMENT INTENDED FOR USE BY A  GENE  SYNTHESIS  PROVIDER
 SHALL  OPERATE  IN  ACCORDANCE  WITH RULES AND REGULATIONS ISSUED BY THE
 DEPARTMENT. THE DEPARTMENT SHALL  UTILIZE  GENERALLY  ACCEPTED  INDUSTRY
 STANDARDS  AND TAKE INTO CONSIDERATION RECOMMENDATIONS AND PROTOCOLS SET
 BY THE INTERNATIONAL GENE  SYNTHESIS  CONSORTIUM  AND/OR  OTHER  SIMILAR
 NATIONALLY OR INTERNATIONALLY RECOGNIZED RELEVANT ORGANIZATIONS TO DRAFT
 SUCH  RULES  AND  REGULATIONS.  FOR  THE  PURPOSE OF THIS SECTION, "GENE
 SYNTHESIS PROVIDER" SHALL MEAN ANY ENTITY THAT SYNTHESIZES AND  DISTRIB-
 UTES SYNTHETIC NUCLEIC ACIDS TO A CUSTOMER OR TO A DISTRIBUTOR.
   § 3. This act shall take effect immediately.
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD04229-05-6



              

2025-S9279A (ACTIVE) - Details

See Assembly Version of this Bill:
A3283
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add Art 32-B §3230, Pub Health L
Versions Introduced in 2023-2024 Legislative Session:
A10095

2025-S9279A (ACTIVE) - Summary

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

2025-S9279A (ACTIVE) - Sponsor Memo

2025-S9279A (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  9279--A
 
                             I N  S E N A T E
 
                             February 24, 2026
                                ___________
 
 Introduced  by Sen. GIANARIS -- read twice and ordered printed, and when
   printed to be committed  to  the  Committee  on  Health  --  committee
   discharged, bill amended, ordered reprinted as amended and recommitted
   to said committee
 
 AN  ACT  to amend the public health law, in relation to the operation of
   gene synthesis providers and manufacturers of gene synthesis equipment

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Short  title. This act shall be known and may be cited as
 the "bioterrorism prevention act".
   § 2. The public health law is amended by adding a new article 32-B  to
 read as follows:
                               ARTICLE 32-B
                            GENE SYNTHESIS LABS
 SECTION 3230. OPERATION OF GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF
                 GENE SYNTHESIS EQUIPMENT.
   §  3230.  OPERATION  OF  GENE SYNTHESIS PROVIDERS AND MANUFACTURERS OF
 GENE SYNTHESIS EQUIPMENT.  ANY GENE SYNTHESIS PROVIDER  OR  MANUFACTURER
 OF  LABORATORY  EQUIPMENT  INTENDED FOR USE BY A GENE SYNTHESIS PROVIDER
 SHALL OPERATE IN ACCORDANCE WITH RULES AND  REGULATIONS  ISSUED  BY  THE
 DEPARTMENT,  INCLUDING  REGULATIONS ON IDENTIFYING POTENTIALLY DANGEROUS
 GENETIC SEQUENCES, SCREENING POTENTIAL CUSTOMERS AND  RETAINING  RECORDS
 OF  GENES  SYNTHESIZED  AND/OR DELIVERED.   THE DEPARTMENT SHALL UTILIZE
 GENERALLY ACCEPTED INDUSTRY STANDARDS AND TAKE INTO CONSIDERATION RECOM-
 MENDATIONS AND PROTOCOLS SET BY THE INTERNATIONAL GENE SYNTHESIS CONSOR-
 TIUM AND/OR OTHER SIMILAR NATIONALLY OR INTERNATIONALLY RECOGNIZED RELE-
 VANT ORGANIZATIONS TO DRAFT SUCH RULES AND REGULATIONS. FOR THE  PURPOSE
 OF  THIS  SECTION,  "GENE SYNTHESIS PROVIDER" SHALL MEAN ANY ENTITY THAT
 SYNTHESIZES AND DISTRIBUTES SYNTHETIC NUCLEIC ACIDS TO A CUSTOMER OR  TO
 A DISTRIBUTOR.
   §  3.  This  act shall take effect on the ninetieth day after it shall
 have become a law.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD04229-07-6

              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.